E2F1 inhibits cellular senescence and promotes oxaliplatin resistance in colorectal cancer

BACKGROUND: Doctors have always been overwhelmed by tumor drug resistance because it is a major challenge in the clinical treatment of tumors. Cellular senescence has a strong relationship with the development of tumor drug resistance. Herein, we aimed to explore new regulatory factors involved in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Haiyang, Zhou, Fangyuan, Li, Runze, Yuan, Jiao, Ye, Lin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009566/
https://www.ncbi.nlm.nih.gov/pubmed/36923082
http://dx.doi.org/10.21037/atm-22-4054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10009566/
https://www.ncbi.nlm.nih.gov/pubmed/36923082
http://dx.doi.org/10.21037/atm-22-4054

Ejemplares similares